255 related articles for article (PubMed ID: 29328364)
1. Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).
Devetzi M; Goulielmaki M; Khoury N; Spandidos DA; Sotiropoulou G; Christodoulou I; Zoumpourlis V
Int J Mol Med; 2018 Mar; 41(3):1177-1186. PubMed ID: 29328364
[TBL] [Abstract][Full Text] [Related]
2. Genetic deficiency in tissue kallikrein activity in mouse and man: effect on arteries, heart and kidney.
Pizard A; Richer C; Bouby N; Picard N; Meneton P; Azizi M; Alhenc-Gelas F
Biol Chem; 2008 Jun; 389(6):701-6. PubMed ID: 18627303
[TBL] [Abstract][Full Text] [Related]
3. Tissue kallikrein in cardiovascular, cerebrovascular and renal diseases and skin wound healing.
Chao J; Shen B; Gao L; Xia CF; Bledsoe G; Chao L
Biol Chem; 2010 Apr; 391(4):345-55. PubMed ID: 20180644
[TBL] [Abstract][Full Text] [Related]
4. Tissue kallikrein is related to the severity of coronary artery disease.
Yao YY; Fu C; Ma GS; Feng Y; Shen CX; Wu GQ; Zhang XG; Ding JD; Tang CC; Chen Z; Dai QM; Tong JY; Luo D; Zhu J; Zhi H; Li YJ; Ju CW; Lu J; Chao J; Chao L
Clin Chim Acta; 2013 Aug; 423():90-8. PubMed ID: 23639635
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin ameliorates influenza virus pathogenesis by inhibition of kallikrein-related peptidase 1-mediated cleavage of viral hemagglutinin.
Leu CH; Yang ML; Chung NH; Huang YJ; Su YC; Chen YC; Lin CC; Shieh GS; Chang MY; Wang SW; Chang Y; Chao J; Chao L; Wu CL; Shiau AL
Antimicrob Agents Chemother; 2015 Sep; 59(9):5619-30. PubMed ID: 26149981
[TBL] [Abstract][Full Text] [Related]
6. Human Tissue Kallikrein 1 Is Downregulated in Elderly Human Prostates and Possesses Potential In Vitro Antioxidative and Antifibrotic Effects in Rodent Prostates.
Zhang M; Luo C; Lin D; Cui K; Chen Z; Liu J
Oxid Med Cell Longev; 2021; 2021():8877540. PubMed ID: 34007408
[TBL] [Abstract][Full Text] [Related]
7. Kallikrein-kinin in stroke, cardiovascular and renal disease.
Chao J; Chao L
Exp Physiol; 2005 May; 90(3):291-8. PubMed ID: 15653716
[TBL] [Abstract][Full Text] [Related]
8. Tissue kallikrein KLK1 is expressed de novo in endothelial cells and mediates relaxation of human umbilical veins.
Dedio J; Wiemer G; Rütten H; Dendorfer A; Schölkens BA; Müller-Esterl W; Wohlfart P
Biol Chem; 2001 Oct; 382(10):1483-90. PubMed ID: 11727832
[TBL] [Abstract][Full Text] [Related]
9. Specific inhibition of tissue kallikrein 1 with a human monoclonal antibody reveals a potential role in airway diseases.
Sexton DJ; Chen T; Martik D; Kuzmic P; Kuang G; Chen J; Nixon AE; Zuraw BL; Forteza RM; Abraham WM; Wood CR
Biochem J; 2009 Aug; 422(2):383-92. PubMed ID: 19527222
[TBL] [Abstract][Full Text] [Related]
10. Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion.
Ma L; Wu J; Zheng Y; Shu Z; Wei Z; Sun Y; Carrell RW; Zhou A
Biomolecules; 2020 May; 10(6):. PubMed ID: 32481593
[TBL] [Abstract][Full Text] [Related]
11. Prolonged hypotensive effect of human tissue kallikrein gene delivery and recombinant enzyme administration in spontaneous hypertension rats.
Sun H; Zhang L; Wang A; Xue Z
Exp Mol Med; 2004 Feb; 36(1):23-7. PubMed ID: 15031667
[TBL] [Abstract][Full Text] [Related]
12. Kallikrein-kinin in stem cell therapy.
Chao J; Bledsoe G; Chao L
World J Stem Cells; 2014 Sep; 6(4):448-57. PubMed ID: 25258666
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-α-activated mesenchymal stem cells promote endothelial progenitor cell homing and angiogenesis.
Kwon YW; Heo SC; Jeong GO; Yoon JW; Mo WM; Lee MJ; Jang IH; Kwon SM; Lee JS; Kim JH
Biochim Biophys Acta; 2013 Dec; 1832(12):2136-44. PubMed ID: 23959047
[TBL] [Abstract][Full Text] [Related]
14. Significance of the tissue kallikrein promoter and transforming growth factor-beta1 polymorphisms with renal progression in children with vesicoureteral reflux.
Lee-Chen GJ; Liu KP; Lai YC; Juang HS; Huang SY; Lin CY
Kidney Int; 2004 Apr; 65(4):1467-72. PubMed ID: 15086490
[TBL] [Abstract][Full Text] [Related]
15. Estrogen-dependent expression of the tissue kallikrein gene (Klk1) in the mouse uterus and its implications for endometrial tissue growth.
Rajapakse S; Yamano N; Ogiwara K; Hirata K; Takahashi S; Takahashi T
Mol Reprod Dev; 2007 Aug; 74(8):1053-63. PubMed ID: 17219431
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal Delivery of Mesenchymal Stem Cells and Endothelial Progenitor Cells Attenuates Hypertensive Cardiomyopathy in Experimental Renovascular Hypertension.
Eirin A; Zhu XY; Ebrahimi B; Krier JD; Riester SM; van Wijnen AJ; Lerman A; Lerman LO
Cell Transplant; 2015; 24(10):2041-53. PubMed ID: 25420012
[TBL] [Abstract][Full Text] [Related]
17. The tissue kallikrein-kinin system protects against cardiovascular and renal diseases and ischemic stroke independently of blood pressure reduction.
Chao J; Bledsoe G; Yin H; Chao L
Biol Chem; 2006 Jun; 387(6):665-75. PubMed ID: 16800727
[TBL] [Abstract][Full Text] [Related]
18. Stem cells in kidney diseases.
Soler MJ; José Tomas OP
J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
[TBL] [Abstract][Full Text] [Related]
19. S(1)' and S(2)' subsite specificities of human plasma kallikrein and tissue kallikrein 1 for the hydrolysis of peptides derived from the bradykinin domain of human kininogen.
Lima AR; Alves FM; Angelo PF; Andrade D; Blaber SI; Blaber M; Juliano L; Juliano MA
Biol Chem; 2008 Dec; 389(12):1487-94. PubMed ID: 18844446
[TBL] [Abstract][Full Text] [Related]
20. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
Conese M; Carbone A; Castellani S; Di Gioia S
Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
